Related Experiment Video
Updated: May 5, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Cardiovascular involvement in patients with different causes of hyperthyroidism
Bernadette Biondi1, George J Kahaly
1Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy. bebiondi@unina.itbebiondi@libero.it
Insights
Hyperthyroidism increases cardiovascular risks, with toxic multinodular goiter posing a higher risk than Graves disease. Understanding the cause of hyperthyroidism is crucial for managing cardiac complications.
Area of Science:
- Endocrinology
- Cardiology
- Internal Medicine
Background:
- Hyperthyroidism, a condition of overactive thyroid, presents with varied effects based on patient age, disease severity, and comorbidities.
- Cardiovascular disease is a significant cause of morbidity and mortality in hyperthyroid patients, but the link between specific cardiac complications and hyperthyroid etiology is not well-defined.
Purpose of the Study:
- To compare the cardiovascular risks associated with different causes of hyperthyroidism, specifically Graves disease, toxic adenoma, and toxic multinodular goiter.
- To investigate how patient age and the specific etiology of hyperthyroidism influence cardiovascular complications.
Main Methods:
- Comparative analysis of cardiovascular risks in patients with Graves disease, toxic adenoma, and toxic multinodular goiter.
- Review of clinical data focusing on age, comorbidities, and specific cardiovascular outcomes.
Main Results:
- Patients with toxic multinodular goiter exhibit a higher cardiovascular risk compared to those with Graves disease.
- Atrial fibrillation, atrial enlargement, and congestive heart failure are common in older patients (≥60 years) with toxic multinodular goiter, especially those with pre-existing heart conditions.
- Graves disease is associated with autoimmune-related cardiac issues, including valve involvement, pulmonary arterial hypertension, and cardiomyopathy.
Conclusions:
- The specific cause of hyperthyroidism significantly impacts cardiovascular risk and complication profiles.
- Establishing the etiology of hyperthyroidism is essential for tailoring treatment strategies for both the thyroid condition and its associated cardiovascular manifestations.
Abstract:
Various clinical disorders can cause hyperthyroidism, the effects of which vary according to the patient's age, severity of clinical presentation and association with other comorbidities. Hyperthyroidism is associated with increased morbidity and mortality from cardiovascular disease, although whether the risk of specific cardiovascular complications is related to the etiology of hyperthyroidism is unknown. This article will focus on patients with Graves disease, toxic adenoma and toxic multinodular goiter, and will compare the cardiovascular risks associated with these diseases. Patients with toxic multinodular goiter have a higher cardiovascular risk than do patients with Graves disease, although cardiovascular complications in both groups are differentially influenced by the patient's age and the cause of hyperthyroidism. Atrial fibrillation, atrial enlargement and congestive heart failure are important cardiac complications of hyperthyroidism and are prevalent in patients aged > or = 60 years with toxic multinodular goiter, particularly in those with underlying cardiac disease. An increased risk of stroke is common in patients > 65 years of age with atrial fibrillation. Graves disease is linked with autoimmune complications, such as cardiac valve involvement, pulmonary arterial hypertension and specific cardiomyopathy. Consequently, the etiology of hyperthyroidism must be established to enable correct treatment of the disease and the cardiovascular complications.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
Graves' Disease I: Introduction
Graves Disease II: Pathophysiology
Hypothyroidism II: Pathophysiology

